Cargando…
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075278/ https://www.ncbi.nlm.nih.gov/pubmed/32047258 http://dx.doi.org/10.1038/s41423-020-0374-2 |
| _version_ | 1783507009744666624 |
|---|---|
| author | Xia, Shuai Zhu, Yun Liu, Meiqin Lan, Qiaoshuai Xu, Wei Wu, Yanling Ying, Tianlei Liu, Shuwen Shi, Zhengli Jiang, Shibo Lu, Lu |
| author_facet | Xia, Shuai Zhu, Yun Liu, Meiqin Lan, Qiaoshuai Xu, Wei Wu, Yanling Ying, Tianlei Liu, Shuwen Shi, Zhengli Jiang, Shibo Lu, Lu |
| author_sort | Xia, Shuai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7075278 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70752782020-03-23 Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein Xia, Shuai Zhu, Yun Liu, Meiqin Lan, Qiaoshuai Xu, Wei Wu, Yanling Ying, Tianlei Liu, Shuwen Shi, Zhengli Jiang, Shibo Lu, Lu Cell Mol Immunol Correspondence Nature Publishing Group UK 2020-02-11 2020-07 /pmc/articles/PMC7075278/ /pubmed/32047258 http://dx.doi.org/10.1038/s41423-020-0374-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Xia, Shuai Zhu, Yun Liu, Meiqin Lan, Qiaoshuai Xu, Wei Wu, Yanling Ying, Tianlei Liu, Shuwen Shi, Zhengli Jiang, Shibo Lu, Lu Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein |
| title | Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein |
| title_full | Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein |
| title_fullStr | Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein |
| title_full_unstemmed | Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein |
| title_short | Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein |
| title_sort | fusion mechanism of 2019-ncov and fusion inhibitors targeting hr1 domain in spike protein |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075278/ https://www.ncbi.nlm.nih.gov/pubmed/32047258 http://dx.doi.org/10.1038/s41423-020-0374-2 |
| work_keys_str_mv | AT xiashuai fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT zhuyun fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT liumeiqin fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT lanqiaoshuai fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT xuwei fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT wuyanling fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT yingtianlei fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT liushuwen fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT shizhengli fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT jiangshibo fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein AT lulu fusionmechanismof2019ncovandfusioninhibitorstargetinghr1domaininspikeprotein |